Campbell & CO Investment Adviser LLC
Position in EW — Edwards Lifesciences Corp
CIK 1353570
BALTIMORE, MD
Position in EW
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,551,208
+$430,621 QoQ
Shares Held
17,148
+19.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#519
of 1,315 holders
Holding Since
Dec 2022
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EW Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Campbell & CO Investment Adviser LLC holds $33,000,533 across 20 Medical Devices names. EW ranks #8 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | STE |
STERIS plc
|
29,009 | $6,108,425 | |
| 2 | BIO |
Bio-Rad Laboratories, Inc.
|
14,056 | $4,126,982 | |
| 3 | ENOV |
Enovis CORP
|
139,970 | $2,897,379 | |
| 4 | HAE |
Haemonetics Corp
|
36,844 | $2,763,300 | |
| 5 | IRTC |
iRhythm Holdings, Inc.
|
22,024 | $2,619,754 | |
| 6 | ABT |
Abbott Laboratories
|
27,012 | $2,451,068 | |
| 7 | PODD |
Insulet Corp
|
12,102 | $1,842,529 | |
| 8 | EW |
Edwards Lifesciences Corp
This page
|
17,148 | $1,551,208 |
All Filings in EW
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,551,208 | 17,148 | Shares | Sole | 2026-08-03 | |
| 2025-09-30 | $1,120,587 | 14,409 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $1,622,466 | 20,745 | Shares | Sole | 2025-08-07 | |
| 2024-09-30 | $203,513 | 3,084 | Shares | Sole | 2024-11-12 | |
| 2023-09-30 | $237,907 | 3,434 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $363,076 | 3,849 | Shares | Sole | 2023-08-11 | |
| 2022-12-31 | $239,125 | 3,205 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||